Key facts
| Price (PPV) | 30.80 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | sulpiride |
| Class | Psycholeptics (antipsychotics, anxiolytics, hypnotics) |
| ATC code | N05AL01 |
| Manufacturer | MAPHAR |
| Presentation | Boîte de 20 |
| Nature | Médicament |
| Hospital price | 19.20 MAD |
| Data collected on | 9/8/2026 |
Indications
- Chez l’adulte : pour traiter certaines formes d’anxiété. - Chez l’adulte et l’enfant de plus de 6 ans : pour traiter certains troubles graves du comportement.
Psychoactive substance / dependence
Oui
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
In Morocco, 2 other products contain the same active substance as Dogmatil 50 mg (Sulpiride), at the same strength and in the same dosage form. For the same pack size (Boîte de 20), the cheapest is Aliviar 50 mg (IBERMA) at 25.20 MAD, i.e. 18 % less than Dogmatil 50 mg (30.80 MAD). The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Aliviar 50 mg | IBERMA | Boîte de 20 | 25.20 MAD | 1.26 / unit | −18 % |
| Sulpidal 50 mg | SYNTHEMEDIC | Boîte de 20 | 26.40 MAD | 1.32 / unit | −14 % |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Dogmatil 50 mg
Dogmatil 50 mg belongs to the psycholeptics (antipsychotics, anxiolytics, hypnotics) therapeutic class. In Morocco, this drug is marketed by MAPHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Dogmatil 50 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Dogmatil 50 mg
Answers to common questions from Moroccan patients about this drug.